Expertise in
6
conditions

Dr. Rudrani Banik

Ophthalmology
310 E 14th St, Suite 319 South, 
New York, NY 
Expertise in
6
conditions
310 E 14th St, Suite 319 South, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rudrani Banik is an Ophthalmologist in New York, New York. Dr. Banik is highly rated in 6 conditions, according to our data. Her top areas of expertise are Papilledema, Optic Nerve Atrophy, Leber Hereditary Optic Neuropathy (LHON), and Increased Intracranial Pressure.

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Ophthalmology
Licenses
Ophthalmology in NY
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

310 E 14th St, Suite 319 South, New York, NY 10003

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Enrollment Status: Completed
Publish Date: August 26, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
External Natural History Controlled, Open-Label Intervention Study to Assess the Efficacy and Safety of Long-Term Treatment With Raxone® in Leber's Hereditary Optic Neuropathy (LHON)
Enrollment Status: Completed
Publish Date: April 21, 2023
Intervention Type: Drug
Study Phase: Phase 4
Randomized Trial of Medical Therapy (MT) vs. MT Plus Optic Nerve Sheath Fenestration vs. MT Plus Ventriculoperitoneal Cerebrospinal Fluid Shunting in Subjects With Idiopathic Intracranial Hypertension and Moderate to Severe Visual Loss
Randomized Trial of Medical Therapy (MT) vs. MT Plus Optic Nerve Sheath Fenestration vs. MT Plus Ventriculoperitoneal Cerebrospinal Fluid Shunting in Subjects With Idiopathic Intracranial Hypertension and Moderate to Severe Visual Loss
Enrollment Status: Terminated
Publish Date: June 16, 2022
Intervention Type: Drug, Procedure
Study Phase: Phase 3
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
A Double-Masked Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Participants With Previous NAION
Enrollment Status: Terminated
Publish Date: October 12, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 Delivered By Single or Multi-Dose Intravitreal Injection(s) to Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Enrollment Status: Terminated
Publish Date: July 20, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

16 Total Publications

Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.
Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.
Journal: Cell reports. Medicine
Published: July 03, 2023
Similar Doctors
Expertise in
52
conditions
Dr. Mark J. Kupersmith
Ophthalmology | Neurosurgery
Expertise in
52
conditions
Dr. Mark J. Kupersmith
Ophthalmology | Neurosurgery

Icahn School Of Medicine At Mount Sinai

17 E 102nd St, Ophthalmology Department O, 
New York, NY 
 (4.4 miles away)
212-241-8118
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Kupersmith is an Ophthalmologist and a Neurosurgery provider in New York, New York. Dr. Kupersmith is highly rated in 52 conditions, according to our data. His top areas of expertise are Papilledema, Increased Intracranial Pressure, Pseudotumor Cerebri Syndrome, Optic Neuritis, and Thymectomy. Dr. Kupersmith is currently accepting new patients.

Expertise in
10
conditions
Dr. Louis R. Pasquale
Ophthalmology
Expertise in
10
conditions
Dr. Louis R. Pasquale
Ophthalmology

Icahn School Of Medicine At Mount Sinai

310 E 14th St, Opthalmology Department Of, 
New York, NY 
 (0.1 miles away)
212-241-0939
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Louis Pasquale is an Ophthalmologist in New York, New York. Dr. Pasquale is highly rated in 10 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Hormone Replacement Therapy (HRT). Dr. Pasquale is currently accepting new patients.

David H. Abramson
Expertise in
10
conditions
Dr. David H. Abramson
Ophthalmology
Expertise in
10
conditions
Dr. David H. Abramson
Ophthalmology

Mskcc Surgery Group

1275 York Ave, 
New York, NY 
 (2.7 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances

David Abramson is an Ophthalmologist in New York, New York. Dr. Abramson is highly rated in 10 conditions, according to our data. His top areas of expertise are Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Banik's expertise for a condition
ConditionClose
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile